Organo Corporation provided consolidated earnings guidance for the six months ending September 30, 2021 and fiscal year ending March 31, 2022. For six months, the company expected net sales of JPY 50,000 million. Operating profit of JPY 2,600. Ordinary profit of JPY 2,550 million. Profit attributable to owners of parent JPY 1,500 million. Basic earnings per share of JPY 130.69. For the year ending March 31, 2022, the company expected net sales of JPY 103,000 million. Operating profit of JPY 8,250. Ordinary profit of JPY 8,150 million. Profit attributable to owners of parent JPY 6,500 million. Basic earnings per share of JPY 566.33.